Skip to main content
Log in

Continuous age- and sex-specific reference ranges of liver enzymes in Chinese children and application in pediatric non-alcoholic fatty liver disease

  • Original Article
  • Published:
World Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Background

Alanine aminotransferase (ALT) is widely used to screen patients with hepatic diseases. However, the current reference ranges (< 50 U/L) were developed by laboratories and have not been validated in populations with a large number of healthy individuals.

Methods

This study collected venous blood and anthropometric data from a total of 13,287 healthy children aged 3 months to 18 years who underwent routine physical examinations in the Department of Pediatric Healthcare. We applied the least mean square algorithm to establish age- and sex-related reference percentiles of serum levels of transaminases. For validation, we recruited 4276 children and adolescents with obesity/overweight who underwent evaluation and metabolic tests in the hospital. Using receiver operating characteristic curves, we determined age- and sex-specific upper limit percentiles of liver enzymes for fatty liver diseases.

Results

This study revealed a significant correlation between serum transaminase levels and age and sex (P < 0.01). These transaminase levels exhibited age- and sex-specific patterns. Among individuals in the non-alcoholic fatty liver disease (NAFLD) cohort, elevated ALT levels displayed a positive association with clinical markers of disease severity, including homeostatic model assessment of insulin resistance, waist–hip ratio, and serum uric acid levels (P < 0.01). According to the receiver operating characteristic curves, ALT levels at the 92.58th percentile for boys and the 92.07th percentile for girls yielded the highest accuracy and specificity.

Conclusions

This study provides age- and sex-specific reference ranges for ALT, aspartate aminotransferase, and γ-glutamyltransferase in Chinese children and adolescents, making it the largest population study to date. Furthermore, the study establishes a precise upper limit for ALT levels, facilitating their use in NAFLD screening.

Video Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

The data sets generated and analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.

References

  1. Nobili V, Alisi A, Valenti L, Miele L, Feldstein AE, Alkhouri N. NAFLD in children: new genes, new diagnostic modalities and new drugs. Nat Rev Gastroenterol Hepatol. 2019;16:517–30.

    Article  PubMed  Google Scholar 

  2. Hesham A-Kader H. Nonalcoholic fatty liver disease in children living in the obeseogenic society. World J Pediatr. 2009;5:245–54.

    Article  CAS  PubMed  Google Scholar 

  3. Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18:223–38.

    Article  PubMed  Google Scholar 

  4. Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017;112:18–35.

    Article  CAS  PubMed  Google Scholar 

  5. Yasuda Y, Miyake N, Matsuoka H, Sugihara S. Adiponectin, ALT and family history as critical markers for the development of type 2 diabetes in obese Japanese children. Endocrinol Diabetes Metab. 2021;4:e00178.

    Article  CAS  PubMed  Google Scholar 

  6. Kang Y, Park S, Kim S, Koh H. Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: a cross-sectional study using data from KNHANES 2010–2015. BMC Pediatr. 2018;18:215.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Lu Y, Wang Q, Yu L, Yin X, Yang H, Xu X, et al. Revision of serum ALT upper limits of normal facilitates assessment of mild liver injury in obese children with non-alcoholic fatty liver disease. J Clin Lab Anal. 2020;34:e23285.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Schwimmer JB, Dunn W, Norman GJ, Pardee PE, Middleton MS, Kerkar N, et al. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology. 2010;138:64.e1–2.

    Google Scholar 

  9. Stirnadel-Farrant HA, Galwey N, Bains C, Yancey C, Hunt CM. Children’s liver chemistries vary with age and gender and require customized pediatric reference ranges. Regul Toxicol Pharmacol. 2015;73:349–55.

    Article  CAS  PubMed  Google Scholar 

  10. Estey MP, Cohen AH, Colantonio DA, Chan MK, Marvasti TB, Randell E, et al. CLSI-based transference of the CALIPER database of pediatric reference intervals from Abbott to Beckman, Ortho, Roche and Siemens Clinical Chemistry Assays: direct validation using reference samples from the CALIPER cohort. Clin Biochem. 2013;46:1197–219.

    Article  PubMed  Google Scholar 

  11. Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, McCullough AJ. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol. 2009;51:1061–7.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Rigby RA, Stasinopoulos DM. Generalized additive models for location, scale and shape. J R Stat Soc Ser C Appl Stat. 2005;54:507–54.

    Article  MathSciNet  Google Scholar 

  13. R Core Team. R: A language and environment for statistical computing R foundation for statistical computing. Vienna, Austria. 2013.

  14. Jin B, Wu Z, Wang S, Yu Z, Ullah R, Liang X, et al. Gender differences in non-alcoholic fatty liver disease in obese children and adolescents: a large cross-sectional study. Hepatol Int. 2023. https://doi.org/10.1007/s12072-023-10596-9.

    Article  PubMed  Google Scholar 

  15. Kohse KP, Thamm M. KiGGS-the German survey on children’s health as data base for reference intervals. Clin Biochem. 2011;44:479.

    Article  PubMed  Google Scholar 

  16. Pan XB, Lu YQ, Lin SZ, Ye J, Wu N, Lou YY, et al. An assessment of upper limits of normal for ALT and the impact on evaluating natural course of chronic hepatitis B virus infection in Chinese children. Am J Gastroenterol. 2018;113:1660–8.

    Article  PubMed  Google Scholar 

  17. Bussler S, Vogel M, Pietzner D, Harms K, Buzek T, Penke M, et al. New pediatric percentiles of liver enzyme serum levels (alanine aminotransferase, aspartate aminotransferase, γ-glutamyltransferase): effects of age, sex, body mass index, and pubertal stage. Hepatology. 2018;68:1319–30.

    Article  CAS  PubMed  Google Scholar 

  18. Ratra S, Dhingra K, Sharma S, Gupta GK, Nijhawan S. Levels of aminotransferases among schoolchildren in Jaipur Rajasthan. Indian Pediatr. 2021;58:683–4.

    Article  PubMed  Google Scholar 

  19. Li X, Wang D, Yang C, Zhou Q, Zhuoga SL, Wang LQ, et al. Establishment of age- and gender-specific pediatric reference intervals for liver function tests in healthy Han children. World J Pediatr. 2018;14:151–9.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Hilsted L, Rustad P, Aksglæde L, Sørensen K, Juul A. Recommended nordic paediatric reference intervals for 21 common biochemical properties. Scand J Clin Lab Invest. 2013;73:1–9.

    Article  CAS  PubMed  Google Scholar 

  21. Hoq M, Matthews S, Karlaftis V, Burgess J, Cowley J, Donath S, et al. Reference values for 30 common biochemistry analytes across 5 different analyzers in neonates and children 30 days to 18 years of age. Clin Chem. 2019;65:1317–26.

    Article  CAS  PubMed  Google Scholar 

  22. Qin ZW, Ren QN, Zhang HX, Liu YR, Huang K, Wu W, et al. Development and validation of a novel non-invasive test for diagnosing nonalcoholic fatty liver disease in Chinese children. World J Pediatr. 2023. https://doi.org/10.1007/s12519-023-00704-y.

    Article  PubMed  Google Scholar 

  23. Hong Y, Ullah R, Wang JB, Fu JF. Trends of obesity and overweight among children and adolescents in China. World J Pediatr. 2023;19:1115–26.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11–20.

    Article  PubMed  Google Scholar 

Download references

Funding

This study was supported by grants from the National Key Research and Development Program of China (Nos. 2021YFC2701901 and 2016YFC1305301), National Natural Science Foundation of China (Nos. 82370863 and 81570759), and Zhejiang Provincial Key Disciplines of Medicine (Innovation Discipline, 11-CX24).

Author information

Authors and Affiliations

Authors

Contributions

WZY contributed to investigation, conceptualization, resources, data curation, methodology, formal analysis, validation, writing of the original draft, reviewing and editing. CSW and OLJ contributed to investigation, conceptualization, methodology, formal analysis, validation, writing of the original draft, reviewing and editing. XXQ, NY and SQ contributed to investigation, conceptualization, resources, and data curation. CJN and JBH contributed to writing of the original draft, reviewing and editing. UR contributed to investigation, conceptualization, writing of the original draft, reviewing and editing. ZXL, HK, WW, DGP, LZM, SY, SJ contributed to resources and data curation. FJF and WW contributed to investigation and conceptualization, and was responsible for funding acquisition and supervision. All authors critically reviewed and approved the final version of the manuscript.

Corresponding authors

Correspondence to Jun-Fen Fu, Qiang Shu or Wei Wu.

Ethics declarations

Ethical approval

This study was approved by the Ethics Committee of Zhejiang University (2021-IRB-301). Informed consent to participate in the study has been obtained from participants (or their parent or legal guardian in the case of children under 16).

Conflict of interest

No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article. Authors Jun-Fen Fu and Qiang Shu are member of the Editorial Board and Chief Editor for World Journal of Pediatrics, respectively. This paper was handled by the other Editor and has undergone rigorous peer-review process. Authors Jun-Fen Fu and Qiang Shu were not involved in the journal’s review of, or decisions related to, this manuscript. The authors have no conflict of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file 2 (PDF 522 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, ZY., Chi, SW., Ouyang, LJ. et al. Continuous age- and sex-specific reference ranges of liver enzymes in Chinese children and application in pediatric non-alcoholic fatty liver disease. World J Pediatr (2024). https://doi.org/10.1007/s12519-023-00789-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12519-023-00789-5

Keywords

Navigation